mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.03 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |